TopFunds

Veeva Systems

NYSE: VEEV

Stock price

284.84 USD

(+0%) TODAY

Health Care TechnologyMedical - Healthcare Information Services
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
0.4
0.5
1
1.5
1.9
2.4
2.6
3
3.2
4.3
5.4
30.5%
02Free cash flow per share
0.4
0.9
1.5
1.9
2.7
3.4
4.6
4.7
5.4
6.5
8.3
35.2%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
409.2
544
690.6
862.2
1,104
1,465
1,851
2,155
2,364
2,747
3,195
22.8%
06% Change
-
-
-
-
-
-
-
-
-
-
-
22.8%
07Cost of revenue
(142.2)
(173.7)
(211.4)
(245.3)
(303.4)
(408.9)
(503.7)
(609.4)
(677.3)
(699.6)
(782)
18.6%
08Gross profit
267
370.4
479.1
616.9
800.7
1,056
1,347
1,546
1,686
2,047
2,413
24.6%
09% Margin
65.3%
68.1%
69.4%
71.6%
72.5%
72.1%
72.8%
71.7%
71.4%
74.5%
75.5%
71.3% A
10Operating expenses
(188.4)
(256.2)
(321.2)
(394.1)
(514.5)
(678.3)
(841.6)
(1,087)
(1,257)
(1,356)
(1,497)
23%
11% of Revenue
(46)%
(47.1)%
(46.5)%
(45.7)%
(46.6)%
(46.3)%
(45.5)%
(50.4)%
(53.2)%
(49.4)%
(46.9)%
(47.6)% A
12Operating Income
78.6
120.7
157.9
222.9
286.2
377.8
505.5
459.1
429.3
691.4
916.4
27.8%
13Income tax expense
(24.2)
(44.8)
(14.6)
(8.8)
(12.6)
(14)
(84.9)
(21.4)
(62.3)
(205.2)
(285.6)
28%
14Net Income
54.5
77.6
151.2
229.8
301.1
380
427.4
487.7
525.7
714.1
908.9
32.5%
15% Margin
13.3%
14.3%
21.9%
26.7%
27.3%
25.9%
23.1%
22.6%
22.2%
26%
28.4%
22.9% A
16Shares Outstanding
145
147.6
153.7
156.1
158.3
160.7
162.3
162.4
163.5
165.2
167
1.4%
17EPS Basic
0.4
0.5
1.1
1.6
2
2.5
2.8
3.1
3.3
4.4
5.6
29.8%
18EPS Diluted
0.4
0.5
1
1.5
1.9
2.4
2.6
3
3.2
4.3
5.4
30.5%
19EBITDA
87.1
134.5
179.5
236.9
306.1
407.2
539.8
538.2
620.7
958.8
1,245
30.5%
% Margin
21.3%
24.7%
26%
27.5%
27.7%
27.8%
29.2%
25%
26.3%
34.9%
39%
28.1% A
20Net Interest Income (expense)
4.6
4.5
8.4
15.4
25.2
15.9
14.7
45.9
133.7
208
-
52.7%
21Net Debt / EBITDA
(1.5)
(1.6)
(1.8)
(2.3)
(1.4)
(1.6)
(2)
(1.5)
(1)
(1.1)
(1.1)
(1.5) A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
132.2
217.6
320.2
551
476.7
730.5
1,138
886.5
703.5
1,119
1,421
26.8%
23Short-term investments
214
301.3
441.8
539.2
610
933.1
1,238
2,216
3,324
4,031
5,140
37.4%
24Accounts receivable
144.8
182.8
238
321.6
422.5
611.6
694.4
785.2
888.5
1,057
1,310
24.6%
25Other current assets
10
10.2
12.4
21.7
21.9
35.6
36.7
81.5
86.9
101.5
126.5
28.9%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
501.2
711.9
1,008
1,433
1,531
2,311
3,107
3,969
5,003
6,309
7,998
31.9%
Non-Current Assets
28Net property, plant & equipment
47.5
49.9
52.3
55
103.9
110.6
104.1
105.2
104.1
119.8
145.9
11.9%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
-
-
30Other non-current assets
157.1
155.9
165.6
165.4
636.8
624.7
605.1
729.8
803.6
911.2
835.8
18.2%
31Total Non-Current Assets
204.6
205.8
217.9
220.4
740.7
735.2
709.3
835
907.7
1,031
981.7
17%
Total Assets
705.8
917.7
1,230
1,654
2,272
3,046
3,817
4,804
5,911
7,340
8,979
29%
LIABILITIES
Current Liabilities
32Accounts payable
4.6
5.7
6.9
9.1
19.4
23.3
20.3
41.7
31.5
30.4
37.6
23.4%
33Short-term debt
-
-
-
-
10
11.7
11
11.3
9.3
10
12.2
3.3%
34Other current liabilities
181.7
241.1
299.2
391.9
521.7
681
809.5
953.8
1,138
1,358
1,587
24.2%
35Total Current Liabilities
186.3
246.8
306.2
401
551.2
716
840.8
1,007
1,179
1,398
1,637
24.3%
Non-Current Liabilities
36Long-term debt
-
-
-
-
44.8
51.4
43.6
49.7
46.4
65.8
83.7
11%
37Other non-current liabilities
14.3
17.9
17.9
15
10.2
12.4
20.4
31.6
40.8
43.2
43.8
11.9%
38Total Non-Current Liabilities
14.3
17.9
17.9
15
55
63.8
64
81.2
87.2
109
127.5
24.5%
39Total Liabilities
200.6
264.7
324.1
416
606.2
779.7
904.8
1,088
1,266
1,507
1,765
24.3%
SHAREHOLDERS` EQUITY
40Common stock
-
-
-
-
-
-
-
-
-
-
-
7.2%
41Retained earnings / (deficit)
143.4
212.2
389.4
619.2
919.7
1,300
1,727
2,215
2,741
3,455
4,364
40.7%
42Accumulated other comprehensive income / (loss)
0.2
0.1
1.6
0.9
0.5
1
(12)
(31.1)
(10.6)
(8.4)
8.2
47.1%
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
505.2
653
906.2
1,238
1,666
2,266
2,912
3,716
4,645
5,832
7,215
30.5%
45Total Liabilities and shareholders' Equity
705.8
917.7
1,230
1,654
2,272
3,046
3,817
4,804
5,911
7,340
8,979
29%
46Total Debt
-
-
-
-
54.8
63.1
54.6
61
55.8
75.8
95.9
9.8%
47Net Debt
(132.2)
(217.6)
(320.2)
(551)
(421.9)
(667.4)
(1,084)
(825.5)
(647.7)
(1,043)
(1,325)
25.9%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
54.5
77.6
151.2
229.8
301.1
380
427.4
487.7
525.7
714.1
908.9
32.5%
49Depreciation & amortization
8.5
13.1
13.7
13.4
26.6
39.3
37
37.7
37.2
50.9
50.5
19.6%
50Share-based compensation expense
-
-
-
-
-
-
-
-
-
-
472.7
-
51Changes in working capital and other assets
17.2
53.3
68.6
67.6
109.7
131.9
300.1
255.1
348.5
325
(16.9)
-
52Net cash flows from operating activities
80.2
144
233.4
310.8
437.4
551.2
764.5
780.5
911.3
1,090
1,415
33.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(22.2)
(7.5)
(11.4)
(9.8)
(4.3)
(8.7)
(14.2)
(13.5)
(26.2)
(20.5)
(29.1)
2.8%
54Purchases of investments / marketable securities
(313.4)
(314.8)
(437.9)
(726.4)
(752.5)
(979.3)
(1,117)
(1,997)
(2,698)
(2,582)
(3,133)
25.9%
55Proceeds from maturities of marketable securities
365
225.6
294.7
632.3
688.1
654.3
792.9
1,003
1,648
1,902
2,058
18.9%
56Other investing activities
(126.1)
0.1
-
-
(448.2)
-
(7.8)
-
-
-
-
(37.1)%
57Net cash flows from investing activities
(96.7)
(96.7)
(154.5)
(103.9)
(516.9)
(333.6)
(346.2)
(1,008)
(1,076)
(700.1)
(1,104)
27.6%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
5.9
12.3
20.8
25.9
11
34.9
51.5
43.7
62.7
105.5
83.9
30.4%
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
-
-
-
-
(1)
(1)
(0.4)
-
-
-
-
(37.5)%
61Other financing activities
13.6
25.6
-
-
-
-
(55.3)
(63)
(78.9)
(79.4)
(93.2)
-
62Net cash flows from financing activities
19.5
38
20.8
25.9
10
33.8
(4.1)
(19.4)
(16.2)
26.1
(9.3)
-
63Increase (decrease) in cash and cash equivalents
2.9
85.4
102.6
230.8
(72.4)
251.9
409.5
(251.6)
(183)
414.3
302.4
59%
64Cash and equivalents, ending balance
132.2
217.6
320.2
552.2
479.8
731.7
1,141
889.7
706.7
1,121
1,423
26.8%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
58
136.5
222.1
301
433.1
542.6
750.2
767
885.1
1,070
1,386
37.4%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2026202520242023202220212020201920182017

Veeva Systems (VEEV) financial statements and performance

Explore Veeva Systems (VEEV) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.